Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial double-stranded DNA is the primary genetic material of bacteria, consisting of long, covalently closed, circular molecules that encode all the information required for bacterial growth, division, and function[3][4][6]. Unlike eukaryotes, bacteria lack a nucleus, so their DNA is located in the cytoplasm, organized as a nucleoid. The chromosome is typically a single circular DNA molecule, although some bacteria have linear chromosomes; most also harbor plasmids, which are smaller circular double-stranded DNA elements capable of horizontal gene transfer[3][5]. The molecule forms a right-handed double helix composed of two antiparallel strands held together by hydrogen bonds between complementary base pairs[2][6]. Bacterial DNA functions as a template for replication (cell division), transcription (RNA synthesis), and indirectly for translation (protein synthesis)[1][4][6]. Many antibiotics target essential processes involving bacterial DNA, such as DNA replication (quinolones inhibit DNA gyrase and topoisomerase IV)[1][5], making bacterial double-stranded DNA a key therapeutic target for antibacterial drugs. Detection of bacterial DNA in clinical specimens serves as a biomarker for bacterial infection. The unique organization, essential function, and susceptibility to specific inhibitors make bacterial double-stranded DNA a validated and clinically important antibacterial drug target.
Inhibition of DNA gyrase and topoisomerase IV, leading to DNA breaks and blockage of replication (quinolones); Direct cross-linking or cleavage of DNA strands (e.g., mitomycin, bleomycin); Disruption of DNA synthesis and function, leading to bactericidal effects
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial double-stranded DNA.